The Quadrivalent Seasonal Influenza Vaccine is a potent blend that efficiently combats multiple influenza strains prevalent in the Northern Hemisphere, covering the United States, Canada, and more. This meticulously designed vaccine boasts a single-dose delivery model, providing an assured dosage of 0.5ml in every vial and minimising waste. Each package contains 3,000 compact units, which are ideal for large-scale vaccination drives in clinics, hospitals, workplaces, or educational institutions.
Featuring a shelf life of at least six months, the Quadrivalent Seasonal Influenza Vaccine equips healthcare providers with exceptional inventory management during the flu season. Its ideal storage and shipping environment falls between 2-8°C, ensuring the preservation of vaccine activity. Additionally, suitable light and freezing protection maintain its efficacy and potency.
Adopting the Quadrivalent Seasonal Influenza Vaccine is a crucial move health providers and individuals can take to diminish the threat of seasonal influenza. It represents a significant step towards maintaining safe and healthy communities during the flu season.